COSENZA, Lucia Carmela
 Distribuzione geografica
Continente #
NA - Nord America 4.546
AS - Asia 2.847
EU - Europa 2.369
SA - Sud America 422
Continente sconosciuto - Info sul continente non disponibili 210
AF - Africa 77
OC - Oceania 25
AN - Antartide 1
Totale 10.497
Nazione #
US - Stati Uniti d'America 4.391
SG - Singapore 1.069
CN - Cina 766
PL - Polonia 757
IT - Italia 567
BR - Brasile 327
VN - Vietnam 275
DE - Germania 256
HK - Hong Kong 203
FR - Francia 164
GB - Regno Unito 130
FI - Finlandia 97
CA - Canada 88
SE - Svezia 79
JP - Giappone 78
UA - Ucraina 73
RU - Federazione Russa 70
ID - Indonesia 68
IN - India 68
TR - Turchia 67
BD - Bangladesh 63
NL - Olanda 45
AR - Argentina 39
MX - Messico 39
ZA - Sudafrica 32
IQ - Iraq 26
IR - Iran 25
PK - Pakistan 25
AU - Australia 20
ES - Italia 20
BE - Belgio 19
CO - Colombia 17
RO - Romania 14
KR - Corea 13
AT - Austria 12
CZ - Repubblica Ceca 12
UZ - Uzbekistan 11
VE - Venezuela 11
EC - Ecuador 9
MY - Malesia 9
SA - Arabia Saudita 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
LV - Lettonia 8
MA - Marocco 8
PH - Filippine 8
KE - Kenya 7
LT - Lituania 7
CH - Svizzera 6
GR - Grecia 6
UY - Uruguay 6
EG - Egitto 5
IE - Irlanda 5
IL - Israele 5
JM - Giamaica 5
NZ - Nuova Zelanda 5
TH - Thailandia 5
TW - Taiwan 5
AZ - Azerbaigian 4
CL - Cile 4
JO - Giordania 4
KG - Kirghizistan 4
KW - Kuwait 4
KZ - Kazakistan 4
PE - Perù 4
PY - Paraguay 4
SD - Sudan 4
AL - Albania 3
DM - Dominica 3
DZ - Algeria 3
GE - Georgia 3
HU - Ungheria 3
NP - Nepal 3
PS - Palestinian Territory 3
PT - Portogallo 3
SV - El Salvador 3
YE - Yemen 3
BB - Barbados 2
BG - Bulgaria 2
ET - Etiopia 2
KH - Cambogia 2
LB - Libano 2
NG - Nigeria 2
PA - Panama 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BT - Bhutan 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
Totale 10.276
Città #
Warsaw 754
Ashburn 674
Singapore 654
San Jose 424
Beijing 320
Woodbridge 215
Santa Clara 209
Chandler 206
Hong Kong 199
Fairfield 196
Ann Arbor 191
Ferrara 182
Council Bluffs 171
Houston 125
Los Angeles 107
New York 101
Dallas 95
Ho Chi Minh City 91
Seattle 89
Munich 88
Jacksonville 84
Wilmington 78
Tokyo 71
Cambridge 67
Addison 59
Hanoi 58
Milan 58
Jakarta 56
Shanghai 55
Bologna 45
Lauterbourg 45
Nanjing 45
Turku 39
Princeton 35
Helsinki 33
Izmir 32
Bremen 30
Redwood City 30
Toronto 29
Orem 28
San Diego 25
Montreal 24
Brooklyn 23
Mexico City 23
São Paulo 23
Buffalo 22
Chicago 22
Hefei 22
London 22
Phoenix 21
Atlanta 20
Chennai 20
Ferrara di Monte Baldo 20
Johannesburg 20
Boardman 19
Rio de Janeiro 19
Brussels 18
Da Nang 18
Denver 17
The Dalles 17
Moscow 15
Boston 14
Dong Ket 14
Frankfurt am Main 14
Rome 14
Shenyang 14
Sydney 14
Poplar 12
Buenos Aires 11
Falkenstein 11
Tashkent 11
Amsterdam 10
Baghdad 10
Des Moines 10
Haiphong 10
Nuremberg 10
Stockholm 10
Ankara 9
Brno 9
Charlotte 9
Columbus 9
Dearborn 9
Nanchang 9
Paris 9
San Francisco 9
Varese 9
Washington 9
Basingstoke 8
Hải Dương 8
Manchester 8
Vienna 8
Zhengzhou 8
Belo Horizonte 7
Curitiba 7
Falls Church 7
Lahore 7
Lappeenranta 7
Ottawa 7
San José 7
Baltimore 6
Totale 6.872
Nome #
A validated cellular biobank for β-thalassemia 420
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 419
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays 380
Cellular and biomolecular technologies for stratification of β thalassemia patients: applications in theranostics 369
A validated THALAMOSS cellular biobank for β-thalassemia 343
Changes in hemoglobin profile reflect autologous blood transfusion misuse in sports 316
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 311
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 303
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 301
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 268
SPR-based non-invasive prenatal testing for fetal sex determination 267
Possible detection of Autologous Blood Transfusion (ABT) based on circulating plasma microRNAs involved in erythroid differentiation and fetal hemoglobin induction 246
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 246
Altered erythroid-related miRNA levels as a possible novel biomarker for detection of autologous blood transfusion misuse in sport 244
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 238
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 229
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 220
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 214
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs 203
Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor 203
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 196
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 195
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 192
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 184
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 180
PCR detection of segmented filamentous bacteria in the terminal ileum of patients with ulcerative colitis 178
New synthetic isoxazole derivatives as potent inducer of fetal hemoglobin (HbF) in beta-thalassemia 177
Analysis of the miRNome as a possible tool for the detection of autologous blood transfusion misuse in sport 171
New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease 161
Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells 155
Evidences for miRNA regulation of BCL11A gene expression 153
Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β039-Globin Gene Editing and Induction of Fetal Hemoglobin 147
Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study 147
Sirolimus-mediated induction of fetal hemoglobin in beta-thalassemia: impact of the XmnI rs74482144 polymophism 145
Down-regulation of LYAR is associated with induction of fetal hemoglobin in mithramycin-treated erythroid cells 144
A β-Thalassemia Cell Biobank: Updates, Further Validation in Genetic and Therapeutic Research and Opportunities During (and After) the COVID-19 Pandemic 139
Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus 137
Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β039-thalassemia patients 135
Targeting miR‑155‑5p and miR‑221‑3p by peptide nucleic acids induces caspase‑3 activation and apoptosis in temozolomide‑resistant T98G glioma cells 130
Increased Expression of α-Hemoglobin Stabilizing Protein (AHSP) mRNA in Erythroid Precursor Cells Isolated from β-Thalassemia Patients Treated with Sirolimus (Rapamycin) 129
Inhibitory effects of SARS-CoV-2 spike protein and BNT162b2 vaccine on erythropoietin-induced globin gene expression in erythroid precursor cells from patients with β-thalassemia 129
Development of a transgenic mouse line carrying a functional human Beta-globin gene with the IVSI-6 thalassemia mutation for in vivo screening and validation of aberrant splicing correctors 124
Effects of Mithramycin on BCL11A Gene Expression and on the Interaction of the BCL11A Transcriptional Complex to γ-Globin Gene Promoter Sequences 117
Sex-specific transcriptional profiles identified in β-thalassemia patients 114
New Synthetic Isoxazole Derivatives Acting as Potent Inducers of Fetal Hemoglobin in Erythroid Precursor Cells Isolated from β-Thalassemic Patients 112
null 107
Treatment of erythroid precursor cells from β‐thalassemia patients with cinchona alkaloids: Induction of fetal hemoglobin production 106
The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies 104
Teaching during COVID-19 pandemic in practical laboratory classes of applied biochemistry and pharmacology: A validated fast and simple protocol for detection of SARS-CoV-2 Spike sequences 103
Anticancer activity of MDM2 inhibition in 2D and bioprinted 3D retinoblastoma cell models 100
Production and Characterization of K562 Cellular Clones Hyper-Expressing the Gene Encoding α-Globin: Preliminary Analysis of Biomarkers Associated with Autophagy 97
The rs368698783 (G>A) Polymorphism Affecting LYAR Binding to the Aγ-Globin Gene Is Associated with High Fetal Hemoglobin (HbF) in β-Thalassemia Erythroid Precursor Cells Treated with HbF Inducers 93
The anti-SARS-CoV-2 BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation and expression of embryo-fetal globin genes in human erythroleukemia K562 cells 76
The Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR) Is under Post-Transcriptional Control of microRNAs: Analysis of the Effects of agomiRNAs Mimicking miR-145-5p, miR-101-3p, and miR-335-5p 76
null 75
Development and characterization of a 3D MCF-7/HFF co-culture spheroid model for evaluating MDM2 inhibition against breast cancer 29
Totale 10.497
Categoria #
all - tutte 45.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.999


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022395 0 31 19 21 24 28 43 25 11 34 26 133
2022/2023512 44 67 15 48 87 51 58 45 48 4 22 23
2023/2024458 15 45 12 10 66 93 43 42 8 9 26 89
2024/20251.645 72 53 139 107 158 152 60 54 296 170 208 176
2025/20264.229 447 153 305 444 625 310 566 267 376 456 183 97
2026/2027352 145 207 0 0 0 0 0 0 0 0 0 0
Totale 10.497